HER2-positive gastric cancer accounts for a substantial proportion of advanced cases and has long been treated with HER2-targeted therapies. While trastuzumab deruxtecan has shown superior activity ...
Researchers at The University of Texas MD Anderson Cancer Center have developed a new computational approach designed to ...
In 2024, Professor Sebastian Kobold's research group at LMU University Hospital had already shown that the metabolite ...
Researchers at The University of Texas MD Anderson Cancer Center have developed a new computational approach designed to ...
An interdisciplinary multi-centre research team led by the LKS Faculty of Medicine (HKUMed) and Faculty of Dentistry at the University of Hong Kong has constructed the world's largest multi-omics ...
Among the most promising tools of cancer therapy, engineered immune cells known as chimeric antigen-receptor (CAR) T cells ...
An Indian review reveals how macrophages are reprogrammed inside breast tumours, helping cancer grow and spread while opening new treatment pathways.
Immunotherapy—which activates the body's own immune system to kill cancer cells—has not worked well against a rare and fatal ...
This infographic explores the core components of the TME, their roles in cancer progression and how they can be leveraged to ...
Existing oncology therapeutics are either so specific they can target only part of a tumor, or so generalized they kill healthy tissue. A new “Tumor Activated Therapy™” in development at the small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results